OverviewSuggest Edit

908 Devices is a company offering handheld and desktop mass spec devices for chemical and biomolecular analysis. It offers a range of products, including rugged, handheld chemical detection tools, compact footprint analyzers, and fast separation devices. The company serves various industries, such as safety and security, oil and gas, life sciences, and other applied markets.

TypePublic
Founded2012
HQBoston, MA, US
Website908devices.com
Employee Ratings4.8

Latest Updates

Employees (est.) (Sept 2020)96
Job Openings26
Revenue (FY, 2019)$18 M(-18%)
Share Price (Oct 2021)$32(-4%)
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at 908 Devices

Kevin J. Knopp

Kevin J. Knopp

CEO & Co-Founder and Director
Christopher D. Brown

Christopher D. Brown

CTO & Co-Founder
Joseph H. Griffith

Joseph H. Griffith

Chief Financial Officer
John Kenneweg

John Kenneweg

VP, Government
Michele Fournier

Michele Fournier

Chief People Officer
Steve Araiza

Steve Araiza

Co-Founder & Software Architect
Show more

908 Devices Office Locations

908 Devices has an office in Boston
Boston, MA, US (HQ)
645 Summer St
Show all (1)

908 Devices Financials and Metrics

908 Devices Revenue

Embed Graph
View revenue for all periods
908 Devices's revenue was reported to be $17.97 m in FY, 2019 which is a 18.5% decrease from the previous period.
USD

Revenue (Q1, 2021)

5.5m

Gross profit (Q1, 2021)

2.9m

Gross profit margin (Q1, 2021), %

52.5%

Net income (Q1, 2021)

(6.1m)

EBIT (Q1, 2021)

(5.8m)

Market capitalization (15-Oct-2021)

874.7m

Closing stock price (15-Oct-2021)

32.0

Cash (31-Mar-2021)

149.0m

EV

747.5m
908 Devices's current market capitalization is $874.7 m.
Annual
USDFY, 2018FY, 2019

Revenue

22.1m18.0m

Revenue growth, %

(19%)

Cost of goods sold

9.7m9.8m

Gross profit

12.4m8.1m
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Revenue

3.0m3.2m3.4m4.0m11.1m6.0m5.5m

Cost of goods sold

1.5m1.7m2.6m1.9m4.7m2.2m2.6m

Gross profit

1.5m1.5m842.0k2.1m6.4m3.8m2.9m

Gross profit Margin, %

49%47%24%52%58%63%52%
Annual
USDFY, 2018FY, 2019

Cash

7.1m17.9m

Accounts Receivable

4.1m5.0m

Inventories

3.5m5.2m

Current Assets

17.2m28.6m
Quarterly
USDQ3, 2020Q1, 2021

Cash

19.7m149.0m

Accounts Receivable

9.3m4.4m

Prepaid Expenses

2.7m

Inventories

4.8m6.8m
Annual
USDFY, 2018FY, 2019

Net Income

(7.5m)(13.4m)

Depreciation and Amortization

896.0k900.0k

Inventories

(989.0k)(1.9m)

Accounts Payable

(1.0m)(12.0k)
Quarterly
USDQ3, 2019Q3, 2020Q1, 2021

Net Income

(12.9m)(2.6m)(6.1m)

Depreciation and Amortization

688.0k610.0k137.0k

Inventories

(2.7m)126.0k(2.5m)

Accounts Payable

387.0k1.1m(787.0k)
USDFY, 2018

Revenue/Employee

243.7k

Debt/Equity

-0.4 x

Debt/Assets

0.6 x

Financial Leverage

-0.6 x
Show all financial metrics

908 Devices Operating Metrics

FY, 2018Q3, 2019FY, 2019Q3, 2020

Product Placements

216125248319

Product Placements to Date

7238489711.29 k

Devices Sold to Date

1.2 k

Customers to Date

300
Show all operating metrics

908 Devices Revenue Breakdown

Embed Graph

908 Devices revenue breakdown by business segment: 14.6% from License and Contract, 12.8% from Consumables and Service and 72.5% from Device Sales

908 Devices revenue breakdown by geographic segment: 7.4% from Asia Pacific, 16.4% from EMEA and 76.2% from North America

908 Devices Online and Social Media Presence

Embed Graph

908 Devices News and Updates

908 Devices to Report Second Quarter Financial Results on August 4, 2021

BOSTON, July 21, 2021 (GLOBE NEWSWIRE) -- 908 Devices Inc., (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will report financial results for the second quarter 2021 before market open on Wednesday, August …

908 Devices to Participate in the William Blair 41st Annual Growth Stock Conference

BOSTON, May 20, 2021 (GLOBE NEWSWIRE) -- 908 Devices Inc., (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will participate virtually in the upcoming William Blair 41st Annual Growth Stock Conference.

908 Devices to Report First Quarter Financial Results on May 13, 2021 and Host 2021 Annual Meeting of Stockholders on June 17, 2021

BOSTON, April 14, 2021 (GLOBE NEWSWIRE) -- 908 Devices Inc., (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will report financial results for the first quarter 2021 before market open on Thursday, May 13, …

908 Devices Reports 50% Top Line Growth, Guides 2021 Up 45%

908 Devices expects 45% revenue growth this year. About 8% below its IPO price, MASS could be a good bet.

908 Devices Reports Fourth Quarter and Full Year 2020 Financial Results and Provides 2021 Revenue Outlook

2020 Revenue Increased 50% Over Prior Year 2020 Revenue Increased 50% Over Prior Year

908 Devices Awarded Multi-Year $25M Purchase Order to Enable the U.S. Army

Multi-mission device will support field teams with trace detection point of need analysis Multi-mission device will support field teams with trace detection point of need analysis
Show more

908 Devices Blogs

908 Devices to Report Third Quarter Financial Results on November 4, 2021

908 Devices Inc., (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will report financial results for the third quarter 2021 before market open on Thursday, November 4, 2021. Company management will webcast a c…

Biotech Week Boston 2021 Takeaways

Top insights include process intensification, rapid decision making, impurity analysis, and metabolite monitoring Biotech Week Boston 2021, which includes BioProcess International and TIDES Oligonucleotide & Peptide Therapeutics, was a jam-packed hybrid event. We were thrilled to attend and lear…

Cooperation, process understanding, and speed are the big takeaways from BPS 2021

The 13th Annual Bioprocessing Summit was a hybrid event this year with some attending in person, others virtually. The 908 Devices team was excited to join in person as it was such a great opportunity to reconnect face-to-face, and shoulder-to-shoulder, with the life sciences community. But let’s, j…

New Update: Threat-Focused Targets

Today, we are pleased to announce the release of the latest MX908 target list update. These updates are critical to allow for new and evolving threats to be detected and identified in the field.   How we choose what targets to add  The MX908 searches for and detects/identifies priority drugs, explos…

Webinar: The Many Applications of Trace Detection in Chemical Response

Join us for our monthly webinar as we delve into the MX908 Hazard Survey Mission Mode and how it can help drive tactical decision making during a chemical event by exploiting trace detection.  Emergency responders can face a variety of chemical hazards, including toxic industrial materials, chemical…

World Smart Bioprocessing: Pharma 4.0 Summit, Berlin, Germany

The World Smart Bioprocessing: Pharma 4.0 Summit will gather world technology leaders from Pharma, Biotech, and Pharma suppliers to share case studies and interactive breakouts towards commercial progress.  Stop by our table! The post World Smart Bioprocessing: Pharma 4.0 Summit, Berlin, Germany app…
Show more

908 Devices Frequently Asked Questions

  • When was 908 Devices founded?

    908 Devices was founded in 2012.

  • Who are 908 Devices key executives?

    908 Devices's key executives are Kevin J. Knopp, Christopher D. Brown and Joseph H. Griffith.

  • How many employees does 908 Devices have?

    908 Devices has 96 employees.

  • What is 908 Devices revenue?

    Latest 908 Devices annual revenue is $18 m.

  • What is 908 Devices revenue per employee?

    Latest 908 Devices revenue per employee is $187.2 k.

  • Who are 908 Devices competitors?

    Competitors of 908 Devices include Clinical Trials of Texas, INFICON and Danaher.

  • Where is 908 Devices headquarters?

    908 Devices headquarters is located at 645 Summer St, Boston.

  • Where are 908 Devices offices?

    908 Devices has an office in Boston.

  • How many offices does 908 Devices have?

    908 Devices has 1 office.